Overview
- Description
Pharmaceutical company focused on the small molecule drug NTP42 for the treatment of pulmonary arterial hypertension (PAH).
- Website
- Country
- Ireland
- Sector
- Health Biotechnology
ATXA Therapeutics Ltd
Pharmaceutical company focused on the small molecule drug NTP42 for the treatment of pulmonary arterial hypertension (PAH).